{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:42Z","timestamp":1759451982226,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.07.095","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:42:30Z","timestamp":1629420150000},"page":"5699-5705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice"],"prefix":"10.1016","volume":"39","author":[{"given":"Ning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianpeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-4601","authenticated-orcid":false,"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2021.07.095_b0005","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1128\/JVI.00071-10","article-title":"Characterization of a putative ancestor of coxsackievirus B5","volume":"84","author":"Gullberg","year":"2010","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2021.07.095_b0010","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1128\/JVI.01709-12","article-title":"Full genome sequence of a novel coxsackievirus B5 strain isolated from neurological hand, foot, and mouth disease patients in China","volume":"86","author":"Hu","year":"2012","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.095_b0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcv.2009.11.013","article-title":"Enteroviruses in Spain over the decade 1998\u20132007: virological and epidemiological studies","volume":"47","author":"Trallero","year":"2010","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"key":"10.1016\/j.vaccine.2021.07.095_b0020","doi-asserted-by":"crossref","first-page":"104516","DOI":"10.1016\/j.jcv.2020.104516","article-title":"Non-polio enterovirus infections in children with central nervous system disorders in Shanghai, 2016\u20132018: Serotypes and clinical characteristics","volume":"129","author":"Li","year":"2020","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.07.095_b0025","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1002\/jmv.26131","article-title":"Distribution of species enterovirus B in patients with central nervous system infections in S\u00e3o Paulo State, Brazil","volume":"92","author":"Compagnoli Carmona","year":"2020","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.095_b0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jmv.23478","article-title":"A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009","volume":"85","author":"Chen","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2021.07.095_b0035","doi-asserted-by":"crossref","unstructured":"Zhang L, Yan J, Ojcius DM, Lv H, Miao Z, Chen Y, et al. Novel and predominant pathogen responsible for the enterovirus-associated encephalitis in eastern China. PLoS ONE. 2013;8:e85023.","DOI":"10.1371\/journal.pone.0085023"},{"issue":"11","key":"10.1016\/j.vaccine.2021.07.095_b0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3201\/eid1811.111457","article-title":"Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007\u20132009","volume":"18","author":"Rao","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.095_b0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2337\/db15-0956","article-title":"Coxsackievirus B5 infection induces dysregulation of microRNSs predicted to target known Type 1 diabetes risk genes in human pancreatic islets","volume":"65","author":"Kim","year":"2016","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.vaccine.2021.07.095_b0050","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/jmv.26096","article-title":"Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population","volume":"92","author":"Sciandra","year":"2020","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.095_b0055","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00705-013-1709-4","article-title":"Recombination in human coxsackievirus B5 strains that caused an outbreak of viral encephalitis in Henan, China","volume":"158","author":"Ma","year":"2013","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.095_b0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jinf.2012.03.021","article-title":"Coxsackievirus B5, associated with neurological hand, foot and mouth disease, China","volume":"65","author":"Hu","year":"2012","journal-title":"J Infect"},{"issue":"20","key":"10.1016\/j.vaccine.2021.07.095_b0065","first-page":"30149","article-title":"Clinical characteristics of echovirus 11 and coxsackievirus B5 infections in Taiwanese children requiring hospitalization","volume":"S1684-1182","author":"Yang","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2021.07.095_b0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/21645515.2017.1384107","article-title":"Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province","volume":"14","author":"Gao","year":"2018","journal-title":"China.[J] .Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.07.095_b0075","unstructured":"Guerra AM, Orille E, Waseem M. Hand Foot And Mouth Disease. 2021 Feb 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing."},{"key":"10.1016\/j.vaccine.2021.07.095_b0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/INF.0000000000002745","article-title":"Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018","volume":"39","author":"Han","year":"2020","journal-title":"The Pediatric infectious disease journal"},{"issue":"17","key":"10.1016\/j.vaccine.2021.07.095_b0085","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1128\/JVI.02856-06","article-title":"An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys","volume":"81","author":"Arita","year":"2007","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.095_b0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.patbio.2010.01.006","article-title":"Hepatitis B vaccines: protective efficacy and therapeutic potential","volume":"58","author":"Michel","year":"2010","journal-title":"Pathologie-biologie."},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.095_b0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vac Therap"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.095_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2249.2011.04559.x","article-title":"Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes","volume":"168","author":"Hober","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.07.095_b0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1469-0691.2006.01476.x","article-title":"Genetic variation of coxsackie virus B5 strains associated with aseptic meningitis in Greece","volume":"12","author":"Papa","year":"2006","journal-title":"Clin Microbiol Infect: Offi Publ Eur Soc Clin Microbiol Infect Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.095_b0110","first-page":"813","article-title":"The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae","volume":"50","author":"Kwag","year":"2012","journal-title":"J Microbiol (Seoul, Korea)."},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.095_b0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1107\/S1744309108007197","article-title":"Crystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle","volume":"64","author":"Wang","year":"2008","journal-title":"Acta Crystallogr, Sect F: Struct Biol Cryst Commun"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.095_b0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.095_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-015-1780-x","article-title":"EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.","volume":"9","author":"Wang","year":"2016","journal-title":"BMC Res Notes."},{"key":"10.1016\/j.vaccine.2021.07.095_b0130","doi-asserted-by":"crossref","unstructured":"Ku Z, Ye X, Huang X, Cai Y, Liu Q, Li Y, et al. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One 2013;8:e57601","DOI":"10.1371\/journal.pone.0057601"},{"issue":"13","key":"10.1016\/j.vaccine.2021.07.095_b0135","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.vaccine.2012.01.061","article-title":"Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis","volume":"30","author":"Zhang","year":"2012","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2021.07.095_b0140","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1007\/s00253-013-5257-3","article-title":"Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice","volume":"97","author":"Zhao","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"issue":"32","key":"10.1016\/j.vaccine.2021.07.095_b0145","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.095_b0150","first-page":"1","article-title":"Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"34","key":"10.1016\/j.vaccine.2021.07.095_b0155","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2016.06.028","article-title":"Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2021.07.095_b0160","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1016\/j.vaccine.2016.06.058","article-title":"Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges","volume":"34","author":"Yan","year":"2016","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2021.07.095_b0165","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1016\/j.vaccine.2010.08.052","article-title":"Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield","volume":"28","author":"Chung","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:23Z","timestamp":1759402943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21010070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21010070"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}